Core Viewpoint - 康臣药业 has proposed a share award plan to incentivize and reward individuals contributing to the company's growth and development, pending shareholder approval at a special meeting [1] Summary by Relevant Sections - Share Award Plan - The board of 康臣药业 has decided to propose the adoption of a share award plan on November 6, 2025 [1] - This plan aims to incentivize and reward participants involved in the company's growth and development [1] - Regulatory Compliance - The proposed share award plan will constitute a new share scheme under Chapter 17 of the Listing Rules [1] - According to Listing Rule 17.02(1)(a), the adoption of the share award plan requires approval from shareholders at a special general meeting [1]